VYNE — VYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.

NAS · US · Healthcare · Biotechnology · vynetherapeutics.com

0.6820USD+1.64%Mkt Cap: 22.66M USDP/E: —Last update: 2026-05-26

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a t…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap22.66M USD

Enterprise Value-2.32M USD

Revenue (TTM)454.00K USD

Gross Profit454.00K USD

Net Income (TTM)-26.48M USD

Revenue/Share0.0110 USD

Last Price0.6820 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees10

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.41

PEG—

EV/EBITDA0.10

EV/Revenue-5.11

P/S49.80

P/B0.81

EPS (TTM)-0.51

EPS (Forward)-1.65

52W Range

0.281024% of range1.960

52W High1.960 USD

52W Low0.2810 USD

Profitability

Gross Margin100.00%

Oper. Margin-4437.21%

EBITDA Margin0.00%

Profit Margin-4646.14%

ROE-95.38%

ROA-87.81%

Growth

Revenue Growth-57.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-33.12M USD

CapEx (TTM)—

FCF Margin-4429.74%

FCF Yield-88.74%

Net Debt-24.93M USD

Net Debt/EBITDA1.02

Balance Sheet

Debt/Equity0.00

Current Ratio20.86

Quick Ratio20.17

Book Value/Sh0.8330 USD

Cash/Share0.7470 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:18

Split DateFeb 13, 2023

Analyst Consensus

Rating2.3 (Buy)

Target (Mean)2.000 USD

Target Range2.000 USD – 2.000 USD

# Analysts1

Ownership

Shares Out.33.35M

Float32.55M

Insiders4.34%

Institutions41.71%

Short Interest

Short Ratio1.2d

Short % Float0.37%

Short % Out.0.36%

Shares Short120.68K

Short (prev mo.)121.53K

Technical

SMA 500.6315 (+8.0%)

SMA 2000.4854 (+40.5%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)200.54K

Avg Vol (10d)192.62K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—